Remove Accountability Remove Life Sciences Remove Pharmaceuticals Remove Telemedicine
article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. The proposed changes would reduce the conversion factor by 4.4%

article thumbnail

Digiceuticals: Driving Growth Through Digital Health Services

HIT Consultant

Subhro Mallik, SVP & Head of Life Sciences at Infosys. There was tremendous interest in telemedicine before 2020. For instance, digital-first healthcare aggregators had been testing programs for telemedicine but, since 2020, the demand for telehealth services has exploded across the globe. Digital Edge for Pharma.

article thumbnail

The Future of Digital Transformation in Hospitals

HIT Consultant

Additionally, digitized health records have been used to make patient information more easily accessible, first to meet Health Insurance Portability and Accountability Act (HIPAA) and HITECH mandates, and now, increasingly, to meet the 21st Century Cures Act ‘Final Rule’ mandate, requiring timely and standardized access to all patient data.